Literature DB >> 25281019

Subcortical structures in amyotrophic lateral sclerosis.

Henk-Jan Westeneng1, Esther Verstraete1, Renée Walhout1, Ruben Schmidt1, Jeroen Hendrikse2, Jan H Veldink1, Martijn P van den Heuvel3, Leonard H van den Berg4.   

Abstract

The aim of this study was to assess the involvement of deep gray matter, hippocampal subfields, and ventricular changes in patients with amyotrophic lateral sclerosis (ALS). A total of 112 ALS patients and 60 healthy subjects participated. High-resolution T1-weighted images were acquired using a 3T MRI scanner. Thirty-nine patients underwent a follow-up scan. Volumetric and shape analyses of subcortical structures were performed, measures were correlated with clinical parameters, and longitudinal changes were assessed. At baseline, reduced hippocampal volumes (left: p = 0.007; right: p = 0.011) and larger inferior lateral ventricles (left: p = 0.013; right: p = 0.041) were found in patients compared to healthy controls. Longitudinal analyses demonstrated a significant decrease in volume of the right cornu ammonis 2/3 and 4/dentate gyrus and left presubiculum (p = 0.002, p = 0.045, p < 0.001), and a significant increase in the ventricular volume in the lateral (left: p < 0.001; right: p < 0.001), 3rd (p < 0.001) and 4th (p = 0.001) ventricles. Larger ventricles were associated with a lower ALSFRS-R score (p = 0.021). In conclusion, ALS patients show signs of neurodegeneration of subcortical structures and ventricular enlargement. Subcortical involvement is progressive and correlates with clinical parameters, highlighting its role in the neurodegenerative process in ALS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Basal ganglia; Hippocampal subfields; Longitudinal; Magnetic resonance imaging

Mesh:

Year:  2014        PMID: 25281019     DOI: 10.1016/j.neurobiolaging.2014.09.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  31 in total

Review 1.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

2.  Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment.

Authors:  Francesca Trojsi; Federica Di Nardo; Giuseppina Caiazzo; Mattia Siciliano; Giulia D'Alvano; Teresa Ferrantino; Carla Passaniti; Dario Ricciardi; Sabrina Esposito; Luigi Lavorgna; Antonio Russo; Simona Bonavita; Mario Cirillo; Gabriella Santangelo; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  Brain Imaging Behav       Date:  2020-10-23       Impact factor: 3.978

Review 3.  Cognitive and behavioral involvement in ALS has been known for more than a century.

Authors:  Stefano Zago; Lorenzo Lorusso; Edoardo N Aiello; Martino Ugolini; Barbara Poletti; Nicola Ticozzi; Vincenzo Silani
Journal:  Neurol Sci       Date:  2022-09-02       Impact factor: 3.830

4.  Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.

Authors:  Leigh E Colvin; Zachariah W Foster; Thor D Stein; Manisha Thakore-James; Mohammad Kian Salajegheh; Kendall Carr; Keith R Spencer; Nazifa Abdul Rauf; Latease Adams; James G Averill; Sean E Walker; Ian Robey; Victor E Alvarez; Bertrand R Huber; Ann C McKee; Neil W Kowall; Christopher B Brady
Journal:  Muscle Nerve       Date:  2022-06-04       Impact factor: 3.852

5.  Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study.

Authors:  Maryse Feron; Annabelle Couillandre; Eya Mseddi; Nicolas Termoz; Malek Abidi; Eric Bardinet; Daniel Delgadillo; Timothée Lenglet; Giorgia Querin; Marie-Laure Welter; Nadine Le Forestier; François Salachas; Gaelle Bruneteau; Maria Del Mar Amador; Rabab Debs; Lucette Lacomblez; Vincent Meininger; Mélanie Pélégrini-Issac; Peter Bede; Pierre-François Pradat; Giovanni de Marco
Journal:  J Neurol       Date:  2018-07-11       Impact factor: 4.849

6.  Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.

Authors:  Elena Ratti; Kimiko Domoto-Reilly; Christina Caso; Alyssa Murphy; Michael Brickhouse; Daisy Hochberg; Nikos Makris; Merit E Cudkowicz; Bradford C Dickerson
Journal:  Brain Imaging Behav       Date:  2021-02-15       Impact factor: 3.224

Review 7.  What does imaging reveal about the pathology of amyotrophic lateral sclerosis?

Authors:  Martin R Turner; Esther Verstraete
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

8.  Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis.

Authors:  Arturo Cardenas-Blanco; Judith Machts; Julio Acosta-Cabronero; Joern Kaufmann; Susanne Abdulla; Katja Kollewe; Susanne Petri; Stefanie Schreiber; Hans-Jochen Heinze; Reinhard Dengler; Stefan Vielhaber; Peter J Nestor
Journal:  Neuroimage Clin       Date:  2016-03-16       Impact factor: 4.881

9.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

10.  MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.

Authors:  Ziqiang Lin; Eugene Kim; Mohi Ahmed; Gang Han; Camilla Simmons; Yushi Redhead; Jack Bartlett; Luis Emiliano Pena Altamira; Isobel Callaghan; Matthew A White; Nisha Singh; Stephen Sawiak; Tara Spires-Jones; Anthony C Vernon; Michael P Coleman; Jeremy Green; Christopher Henstridge; Jeffrey S Davies; Diana Cash; Jemeen Sreedharan
Journal:  Brain Commun       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.